Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

Nearly one-third of patients who responded to a survey did not understand common skin cancer terms frequently used by ...

Eating more anti-inflammatory and antioxidant-rich foods may slow biological aging and help reduce the risk of skin cancer, according to a study published in Cancers.1 ...

Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...

In 2025, over 200,000 Americans were diagnosed with skin cancer. Thankfully, five months ago, U.S. Dermatology Partners ...

Moderna and Merck said on Tuesday their experimental vaccine for a serious type of skin cancer, when used with Keytruda, ...